Literature DB >> 1723362

Drug antioxidant effects. A basis for drug selection?

B Halliwell1.   

Abstract

A free radical is any species capable of independent existence that contains one or more unpaired electrons. Free radical reactions have been implicated in the pathology of more than 50 human diseases. Radicals and other reactive oxygen species are formed constantly in the human body, both by deliberate synthesis (e.g. by activated phagocytes) and by chemical side-reactions. They are removed by enzymic and nonenzymic antioxidant defence systems. Oxidative stress, occurring when antioxidant defences are inadequate, can damage lipids, proteins, carbohydrates and DNA. A few clinical conditions are caused by oxidative stress, but more often the stress results from the disease. Sometimes it then makes a significant contribution to the disease pathology, and sometimes it does not. Several antioxidants are available for therapeutic use. They include molecules naturally present in the body [superoxide dismutase (SOD), alpha-tocopherol, glutathione and its precursors, ascorbic acid, adenosine, lactoferrin and carotenoids] as well as synthetic antioxidants [such as thiols, ebselen (PZ51), xanthine oxidase inhibitors, inhibitors of phagocyte function, iron ion chelators and probucol]. The therapeutic efficacy of SOD, alpha-tocopherol and ascorbic acid in the treatment of human disease is generally unimpressive to date although dietary deficiencies of the last two molecules should certainly be avoided. Xanthine oxidase inhibitors may be of limited relevance as antioxidants for human use. Exciting preliminary results with probucol (antiatherosclerosis), ebselen (anti-inflammatory), and iron ion chelators (in thalassaemia, leukaemia, malaria, stroke, traumatic brain injury and haemorrhagic shock) need to be confirmed by controlled clinical trials. Clinical testing of N-acetylcysteine in HIV-1-positive subjects may also be merited. A few drugs already in clinical use may have some antioxidant properties, but this ability is not widespread and drug-derived radicals may occasionally cause significant damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723362      PMCID: PMC7102057          DOI: 10.2165/00003495-199142040-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  296 in total

Review 1.  Reactive oxygen species, antioxidants, and acquired immunodeficiency syndrome. Sense or speculation?

Authors:  B Halliwell; C E Cross
Journal:  Arch Intern Med       Date:  1991-01

2.  Animal toxicology of iron chelator L1.

Authors:  J B Porter; K P Hoyes; R Abeysinghe; E R Huehns; R C Hider
Journal:  Lancet       Date:  1989-07-15       Impact factor: 79.321

Review 3.  Superoxide dismutase therapy for myocardial ischemia.

Authors:  J M Downey; B Omar; H Ooiwa; J McCord
Journal:  Free Radic Res Commun       Date:  1991

4.  Normal alveolar epithelial lining fluid contains high levels of glutathione.

Authors:  A M Cantin; S L North; R C Hubbard; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1987-07

5.  Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids from patients suffering from arthritis.

Authors:  B Meier; H H Radeke; S Selle; H H Raspe; H Sies; K Resch; G G Habermehl
Journal:  Free Radic Res Commun       Date:  1990

6.  The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complex.

Authors:  O I Aruoma; B Halliwell; M J Laughton; G J Quinlan; J M Gutteridge
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

7.  Oxygen, oxidases, and the essential trace metals.

Authors:  H A Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1981-08-14       Impact factor: 6.237

8.  The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes.

Authors:  G Saez; P J Thornalley; H A Hill; R Hems; J V Bannister
Journal:  Biochim Biophys Acta       Date:  1982-10-28

9.  The protective action of allopurinol in an experimental model of haemorrhagic shock and reperfusion.

Authors:  G Allan; D Cambridge; L Lee-Tsang-Tan; C W Van Way; M V Whiting
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

10.  Inhibitory effects of ebselen on lipid peroxidation in rat liver microsomes.

Authors:  M Hayashi; T F Slater
Journal:  Free Radic Res Commun       Date:  1986
View more
  52 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

3.  Reconvene and reconnect the antioxidant hypothesis in human health and disease.

Authors:  P P Singh; Anu Chandra; Farzana Mahdi; Ajanta Roy; Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2010-09-03

4.  Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats.

Authors:  M Sharma; K Kishore; S K Gupta; S Joshi; D S Arya
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

5.  Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

Authors:  Aurelio Jara-Prado; Alberto Ortega-Vazquez; Leticia Martinez-Ruano; Camilo Rios; Abel Santamaria
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

6.  Chemopreventive potential of Epoxy clerodane diterpene from Tinospora cordifolia against diethylnitrosamine-induced hepatocellular carcinoma.

Authors:  Muniyappan Dhanasekaran; Arul-Albert Baskar; Savarimuthu Ignacimuthu; Paul Agastian; Veeramuthu Duraipandiyan
Journal:  Invest New Drugs       Date:  2008-10-14       Impact factor: 3.850

7.  The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

Authors:  Anping Chen; Li Zhang; Jianye Xu; Jun Tang
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress.

Authors:  Jianguo Lin; Shizhong Zheng; Anping Chen
Journal:  Lab Invest       Date:  2009-10-19       Impact factor: 5.662

9.  Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

10.  Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.